CIC Services Wins Precedent-setting U S Supreme Court Case Against the Internal Revenue Service in Unanimous Decision
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
CIC Services Wins Precedent-setting U S Supreme Court Case Against the Internal Revenue Service in Unanimous Decision
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Steel prices: How we got here and what could happen
History suggests the steel tariffs were a bad idea; current events reinforce that notion
A combination of increased demand and lack of supply has helped to drive up hot- rolled steel coil prices to more than $1,600/ton in May. Removing the Section 232 tariffs on imported steel and aluminum would provide price relief for steel consumers.
Getty Images.
For more than 100 years, the federal government has been implementing quotas or tariffs on imported steel to support domestic steel producers. Historically, government action in the steel market arises in times of low steel prices as a means of supporting steel producers and marketed for political purposes to attract support from voters, particularly in the Rust Belt. As a result, steelmaking jobs might have been saved, but a far greater number of jobs in steel-consuming industries, including the metal fabrication sector, were lost. As with any tariff and quota action, the U.S. eco
Dear Members of Congress:
We, the members of the Coalition Against Socialized Medicine (CASM), a coalition of leading conservative and free-market organizations representing millions of taxpayers, patients, and voters, urge members of Congress to oppose price-setting schemes such as those found in H.R. 3, a retread of the so-called “Lower Drug Costs Now Act” from the previous Congress. Such dangerous, far-left drug pricing schemes would ultimately lead to a socialist system that includes access restrictions and a flight of biopharmaceutical innovation from the U.S., depriving America’s patients of the life-saving treatments and cures of tomorrow.
Price-setting schemes like H.R.3 would ultimately allow bureaucrats in foreign countries to determine what Americans pay for and how they access their medicines. A look at the health care systems in foreign countries with price-setting schemes reveals their dire, real-world impacts on patients – and what potentially awaits American